Pulmonix
Pulmonix Research LLC is dedicated to transforming lung health through clinical research, focusing on treatments for pulmonary fibrosis, asthma, and other pulmonary conditions. They are involved in various clinical trials, research publications, and community awareness initiatives, aiming to improve patient outcomes and advance pulmonary medicine.
Industries
Nr. of Employees
small (1-50)
Services
Operational conduct of interventional and observational clinical trials focused on pulmonary fibrosis, ILD, asthma and related conditions; site management and patient enrollment.
Patient identification, screening and enrollment support including use of point-of-care alerting to identify hospitalized candidates for trials.
Collaborative research, authorship and contribution to peer-reviewed studies and registry analyses in pulmonary medicine.
Participation in prospective validation studies of molecular classifiers and diagnostic workflows applied to lung biopsy samples.
Public-facing outreach, educational materials and awareness activities addressing lung disease, vaping-related illness, and pulmonary fibrosis awareness.
Operational conduct of interventional and observational clinical trials focused on pulmonary fibrosis, ILD, asthma and related conditions; site management and patient enrollment.
Patient identification, screening and enrollment support including use of point-of-care alerting to identify hospitalized candidates for trials.
Collaborative research, authorship and contribution to peer-reviewed studies and registry analyses in pulmonary medicine.
Participation in prospective validation studies of molecular classifiers and diagnostic workflows applied to lung biopsy samples.
Public-facing outreach, educational materials and awareness activities addressing lung disease, vaping-related illness, and pulmonary fibrosis awareness.
Expertise Areas
- Clinical trial management
- Patient recruitment and enrollment
- Interstitial lung disease and pulmonary fibrosis research
- Early-phase clinical trials
Key Technologies
- Point-of-care real-time alert systems
- Molecular diagnostic classifiers for lung tissue
- Transbronchial lung biopsy techniques
- Real-world evidence analytics and causal inference methods
News & Updates
A study investigating the impact of antifibrotic therapy on mortality and outcomes in IPF patients.
An awareness campaign marking Pulmonary Fibrosis Awareness Month with community participation.
Recognition of healthcare professionals contributing to lung health and pulmonary care.
Publication of research on delirium treatment in critical illness.
Introduction of Trelegy, a new inhaler approved for COPD exacerbations.
Validation study on molecular classification in lung biopsy samples.
A study investigating the impact of antifibrotic therapy on mortality and outcomes in IPF patients.
An awareness campaign marking Pulmonary Fibrosis Awareness Month with community participation.
Recognition of healthcare professionals contributing to lung health and pulmonary care.
Publication of research on delirium treatment in critical illness.
Introduction of Trelegy, a new inhaler approved for COPD exacerbations.
Validation study on molecular classification in lung biopsy samples.